HLA Antigens in Insulin-Dependent Diabetes Mellitus

References

• Barnett A H, Eff C, Leslie R DG, Pyke D A. Diabetes in identical twins: a study of 200 pairs. Diabetologia 1981; 20: 87–93
   PubMed Web of Science ®Google Scholar
• Diabetes Epidemiology Research International Group. Geographic patterns of childhood insulin-dependent diabetes mellitus. Diabetes 1988; 37: 1113–9
   PubMed Web of Science ®Google Scholar
• Dowse G K, Zlmmet P Z. The prevalence and incidence of non-insulin-dependent diabetes mellitus. Alberti KGMM, Mazze RS. Frontiers of diabetes research: current trends in non-insulin-dependent diabetes mellitus. Elsevier Science Publishers B.V., Amsterdam 1989; 859: 37–59
   Google Scholar
• Nerup J, Platz P, Andersson O O, et al. HL-A antigens and diabetes mellitus. Lancet 1974; 2: 864–6
   PubMed Web of Science ®Google Scholar
• Cudworth A G, Woodrow J C. Evidence for HL-A linked genes in juvenile diabetes mellitus. Brit Med J 1975; 3: 133–5
   PubMed Web of Science ®Google Scholar
• Bill G I, Picket R L, Rutter W J, Cordell B, Tischer E, Goodman H M. Sequence of the human insulin gene. Nature 1980; 284: 26–32
   PubMedGoogle Scholar
• Ullrich A, Bell J R, Chen E Y, et al. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 1985; 313: 756–61
   PubMed Web of Science ®Google Scholar
• Mueckler M, Caruso C, Baldwin S A, et al. Sequence and structure of a human glucose transporter. Science 1985; 229: 941–5
   PubMed Web of Science ®Google Scholar
• Luo Li C-C W-H, Moore M N, Chan L. Structure and evolution of the apolipoprotein multigene family. J Mol Biol 1986; 187: 325–40
   PubMedGoogle Scholar
• Briggs B R, Botha M C, Jackson W PU, DuTolt E D. The histocompatibility (HLA) antigen distribution in South African Blacks (Xhosa). Diabetes 1980; 29: 68–70
   PubMed Web of Science ®Google Scholar
• Williams C, Knowler W C, Butler W J, et al. HLA-A2 and Type 2 (insulin independent) diabetes mellitus in Pima Indians: an association of allele frequency with age. Diabetologia 1981; 21: 460–3
   PubMed Web of Science ®Google Scholar
• Serjeantson S W, Ryan D P, Ram P, Zimmet P. HLA and non-insulin-dependent diabetes mellitus in Fiji Indians. Med J Aust 1981; 1: 462–3
   PubMed Web of Science ®Google Scholar
• Groop L, Koskimies S, Pelkonen R, Tolppanen E-M. Increased frequency of HLA-Cw4 in type 2 diabetes. Acta Endocrinol 1983; 104: 475–8
   PubMedGoogle Scholar
• Serjeantson S W, Zimmet P. Genetics of NIDDM: pilgrim's progress. Alberti KGMM, Mazze RS. Frontiers of diabetes research: current trends in non-insulin-dependent diabetes mellitus. Elsevier Science Publishers B.V., Amsterdam 1989; 859: 21–35
   Google Scholar
• Immunobiology of HLA, B Dupont. Springer-Verlag, New York 1989; 2
   Google Scholar
• Spies T, Blanck G, Bresnahan M, Sands J, Strominger J L. A new cluster of genes within the Human Major Histocompatibility Complex. Science 1989; 243: 214–7
   PubMed Web of Science ®Google Scholar
• Bodmer J G, Marsh S GE, Albert E. Nomenclature for factors of the HLA system, 1989. Immunology Today 1990; 11: 3–10
   PubMedGoogle Scholar
• Dausset J, Colombani J. Histocompatibility Testing 1972. Munksgaard, Copenhagen 1973
   Google Scholar
• Wakisakl A, Aizawa M, Matsuura N, et al. HLA and juvenile diabetes mellitus in the Japanese. Lancet 1976; 2: 970
   Google Scholar
• Tuomilehto-Wolf E, Tuomilehto J, Cepaitis Z, Lounamaa R, the DIME study group. New susceptibility haplotype for type 1 diabetes. Lancet 1989; 2: 299–302
   PubMed Web of Science ®Google Scholar
• Wolf E, Spencer K M, Cudworth A G. The genetic susceptibility to Type 1 (insulin dependent) diabetes: analysis of the HLA-DR association. Diabetologia 1983; 24: 224
   PubMed Web of Science ®Google Scholar
• Wolf E. Different linkage disquilibrium in type 1 diabetic and “healthy” HLA haplotypes. Prognosis of Diabetes in Children. Pediatr Adolesc Endocrinol, Z Laron, M Karp. Krager, Basel 1988; 18: 270–4
   Google Scholar
• Bach F H, Rich S S, Barbosa J, Segall M. Insulin-dependent diabetes-associated HLA-D region encoded determinants. Hum Immunol 1985; 12: 59–64
   PubMedGoogle Scholar
• Finkelstein S, Zeller E, Walford R L. No relationship between HL-A and juvenile diabetes. Tissue Antigens 1972; 2: 74–7
   PubMedGoogle Scholar
• Singal D P, Blajchman M A. Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes 1983; 22: 429–32
   Google Scholar
• Nerup J, Platz P, Andersson O O, et al. HL-A antigens and diabetes mellitus. Lancet 1974; 2: 864–6
   PubMed Web of Science ®Google Scholar
• Cudworth A G, Woodrow J C. Evidence for HL-A linked genes in juvenile diabetes mellitus. Br Med J 1975; 3: 133–5
   PubMed Web of Science ®Google Scholar
• Contu L, Deschamps I, Lestradet H, et al. HLA haplotype study of 53 juvenile isnulin-dependent (IDD) families. Tissue Antigens 1982; 20: 123–40
   PubMedGoogle Scholar
• Batchelor J R, Morris P J. HLA and disease. Histocompatibility Testing 1977, W F Bodmer, J R Batchelor, J G Bodmer, H Festenstein, P J Morris. Munksgaard, Copenhagen 1978; 205–58
   Google Scholar
• Thomsen M, Platz P, Andersen O O, et al. MLC typing in juvenile diabetes mellitus and idiopathic Addison's disease. Transplant Rev 1975; 22: 125–47
   PubMedGoogle Scholar
• Svejgaard A, Platz P, Ryder L P. Insulin-dependent diabetes mellitus. Histocompatibility Testing, 1980, P I Terasaki. UCLA, Tissue Typing Laboratory, Los Angeles 1980; 638–56
   Google Scholar
• Bertrams J, Baur M P. Insulin-dependent diabetes mellitus. Histocompatibility Testing 1984, E D Albert, W R Mayr. Springer-Verlag, Berlin 1984; 348–58
   Google Scholar
• Johnston C, Pyke D A, Cudworth A G, Wolf E. HLA-DR typing in identical twins with insulin-dependent diabetes: difference between concordant and discordant pairs. Br Med J 1983; 286: 253–5
   PubMedGoogle Scholar
• Rubinstein P, Walker M, Ginsberg-Fellner F. Excess of DR3/4 in type 1 diabetes: what does it portend?. Diabetes 1986; 35: 985–9
   PubMedGoogle Scholar
• Winnearls B, Bodmer J, Bodmer W F, et al. A family study of the association between insulin dependent diabetes mellitus, autoantibodies and the HLA system. Tissue Antigens 1984; 24: 234–6
   PubMedGoogle Scholar
• Matsuda A, Kuzuya T, Iwamoto Y, et al. HLA DR antigens in adult-onset and juvenile-onset Japanese insulin-dependent diabetic patients. Diabetes Res Clin Pract 1988; 5: 197–12
   PubMedGoogle Scholar
• Raum D, Alper C A, Stein R, Gabbay K H. Genetic marker for insulin-dependent diabetes mellitus. Lancet 1979; 1: 1208–10
   PubMed Web of Science ®Google Scholar
• Bertrams J, Hintzen U, Schlicht V, Schoeps S. C4: another marker for Type 1 diabetes. Lancet 1982; 1: 41
   PubMedGoogle Scholar
• Ilonen J, Åkerblom H K, Tiilikainen A, Mustonen A, Herva E, Koskimies S, Kouvalainen K. Increase of HLA haplotype A9-Bw16 in familial insulin-dependent diabetes mellitus in Northern Finland. Acta Diabetol Lat 1982; 19: 167–74
   PubMedGoogle Scholar
• Walker A, Cudworth A G. Type 1 (insulin dependent) diabetic multiplex families: mode of genetic transmission. Diabetes 1980; 29: 1036–9
   PubMedGoogle Scholar
• Tarn A C, Thomas J M, Dean B M, et al. Predicting insulin-dependent diabetes. Lancet 1988; 2: 845–50
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, Podar T, Reunanen A, et al. Comparison of the incidence of insulin-dependent diabetes mellitus in childhood between Finland and Estonia, 1980–1988. Diabetes Care 1991, (in press)
   Google Scholar
• Carcassi C, Trucco G, Trucco M, Contu L. An HLA-DR2 haplotype confers susceptibility to Type 1 diabetes in Sardinia. Diabetes 1990; 39 (suppl 1): 60A
   Google Scholar
• Cudworth A G, Wolf E, Gorsuch A N, Festenstein H. A new look at HLA genetics with particular reference to type 1 diabetes. Lancet 1979; 2: 389–91
   PubMedGoogle Scholar
• Miller A P, Rich S, Barbosa J. Insulin-dependent diabetic families: sex ratio and HLA haplotype segregation. Lancet 1981; 1: 388
   PubMedGoogle Scholar
• Vadhelm C M, Rotter J I, Maclaren N K, Riley W J, Anderson E A. Preferential transmission of diabetic alleles within the HLA gene complex. N Engl J Med 1986; 20: 1314–8
   Google Scholar
• Awdeh Z L, Raum D, Yarvis E J, Alper C A. Extended HLA/ complement allele haplotypes: evidence for T/t-like complex in man. Proc Natl Acad Sci USA 1986; 80: 259–63
   Google Scholar
• Tuomilehto-Wolf E, Tuomilehto J, Lappivaara J, Cepaitis A. and the DiMe Study Group. Estimation of haplotype specific absolute risk in type 1 diabetes in Finland. Diabetologia 1990; 33: 44A
   Google Scholar
• Owerbach D, Lernmark A, Platz P, et al. HLA-A region beta-chain DNA endonuclease fragments differ between HLA-DR identical healthy individuals and insulin-dependent diabetic individuals. Nature 1983; 303: 815–7
   PubMed Web of Science ®Google Scholar
• Morel P A, Dorman J S, Todd J A, McDevitt H O, Trucco M. Aspartic acid at position 57 of the HLA-DQ β chain protects against type 1 diabetes: a family study. Proc Natl Acad Sci, USA 1988; 85: 8111–5
   PubMed Web of Science ®Google Scholar
• Markussen G, Ronningen K S, Paulsen G, Gaudernack G, Sollid L M, Thorsby E. HLA-DQw3.1 and DQw3.2 associated exon polymorphisms detected by oligonucleotide probes. Tissue Antigens 1988; 31: 204–10
   PubMedGoogle Scholar
• Todd J A, Bell J I, McDevitt H O. HLA-DQ β gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987; 329: 599–604
   PubMed Web of Science ®Google Scholar
• Dorman J S, LaPorte R E, Stone R A, Trucco M. Worldwide differences in the incidence of type 1 diabetes are associated with amino acid variation at position 57 of the HLA-DQ beta chain. Proc Natl Acad Sci USA 1990; 87: 7370–4
   PubMed Web of Science ®Google Scholar
• Nepom B S, Schwarz D, Palmer J P, Nepom G T. Transcomplementation of HLA genes in IDDM: HLA DQalpha and beta chains produce hybrid molecules in DR3/4 heterozygous. Diabetes 1987; 36: 114–7
   PubMed Web of Science ®Google Scholar
• Khalil I, d'Auriol L, Gobet M, et al. A combination of HLA-DQbeta Asp57-negative and HLA-DQalpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest 1990; 85: 1315–9
   PubMed Web of Science ®Google Scholar
• Ehrlich H A. PR. technology: principles and applications for DNA amplification. Stockton/Macmillam, New York 1989
   Google Scholar
• Neel J V. The genetics and epidemiology of chronic diseases, J V Neel, M W Shaw, W J Schull. Public Health Service Publication, Washington, DC 1965; 105–32
   Google Scholar
• McDonald M J, Gottschalk J, Hunter J B, Winter K L. HLA-DR4 in insulin-dependent diabetic parents and their offspring: a clue to dominant inheritance. Proc Natl Acad Sci USA 1986; 83: 7049–53
   PubMed Web of Science ®Google Scholar
• Rubinstein P, Sucio-Foca N, Nicholson J F. Genetics of juvenile diabetes mellitus. N Engl J Med 1977; 297: 1036–40
   PubMedGoogle Scholar
• Spielman R S, Baker L, Zmijewski C M. Gene dosage and susceptibility to insulin-dependent diabetes. Ann Hum Genet 1980; 44: 135–50
   PubMed Web of Science ®Google Scholar
• Thomson G. A two locus model for juvenile diabetes. Ann Hum Genet, (London) 1980; 43: 383–98
   PubMedGoogle Scholar
• Hors J, Deschamp I, Schuler E. Genetic Analysis Workshop IV: some clinical, pathological and etiological aspects of two HLA-related diseases. Genet Epidemiol 1986; 291–7, suppl 1
   Google Scholar
• Genetic Analysis of complex traits. Part I: insulin-dependent diabetes mellitus. Genet Epidemiol 1989; 6
   Google Scholar
• Tiwari J L, Terasaki P I. HLA and disease associations. Springer-Verlag, Berlin 1985
   Google Scholar
• Maeda H, Takeuchi F, Juji T, et al. HLA-DRw3 in juvenile onset diabetes mellitus in Chinese. Tissue Antigen 1980; 15: 173–6
   PubMedGoogle Scholar
• Hodge S E, Anderson C E, Neiswanger K, et al. Close genetic linkage between diabetes mellitus and Kidd blood group. Lancet 1981; 2: 893–5
   PubMedGoogle Scholar
• Vague P H, Melis C, Mercier P, Vialettes B, Lassmann V. The increased frequency of the Lewis negative blood group in a diabetic population 1978; 15: 33–6
   Google Scholar
• Field L L, Dugoujon J-M. Immunoglobulin allotyping (Gm, Km) of GAW5 families. Genet Epidemiol 1989; 6: 31–3
   PubMedGoogle Scholar
• Mattila M J, Tiitinen H. The rate of isoniazid inacrivation in Finnish diabetic and non-diabetic patients. Ann Med Exp Biol Fenn 1967; 45: 423–7
   PubMedGoogle Scholar
• McLaren E H, Burden A C, Moorhead P J. Acetylator pheno-type in diabetic neuropathy. Br Med J 1977; 2: 291–3
   PubMedGoogle Scholar
• Bodansky H J, Drury P L, Cudworth A G, Evans Price D A. Acetylator phenotypes and Type 1 (insulin-dependent) diabetics with microvascular disease. Diabetes 1981; 30: 907–10
   PubMed Web of Science ®Google Scholar
• Hitman G A, Jowett N I, Williams L G, Humphries S, Winter R M, Galton D J. Polymorphisms in the 5′-flanking region of the insulin gene and non-insulin-dependent diabetes. Clin Sci 1984; 66: 383–8
   Google Scholar
• Millward B A, Wells K I, Leslie R DG, Pyke D A, Demaine A G. T cell receptor beta chain polymorphisms are associated with insulin-dependent diabetes. Clin Exp Immunol 1987; 70: 152–157
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, Wolf E. Primarypreventionofdiabetesmellitus. Diabetes Care 1987; 10: 238–48
   PubMedGoogle Scholar